Let’s start up with the current stock price of Arcturus Therapeutics Holdings Inc. (ARCT), which is $62.89 to be very precise. The Stock rose vividly during the last session to $72.48 after opening rate of $69.50 while the lowest price it went was recorded $62.48 before closing at $69.67.
Recently in News on January 6, 2021, Arcturus Therapeutics to Present at Upcoming Investor Conference. Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will participate in a panel discussion taking place at the 13th Annual Biotech Showcase™ Investor Conference:. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Arcturus Therapeutics Holdings Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $81.35 on 01/08/21, with the lowest value was $43.74 for the same time period, recorded on 01/04/21.
Arcturus Therapeutics Holdings Inc. (ARCT) full year performance was 418.89%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Arcturus Therapeutics Holdings Inc. shares are logging -51.51% during the 52-week period from high price, and 639.01% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $8.51 and $129.71.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2339054 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Arcturus Therapeutics Holdings Inc. (ARCT) recorded performance in the market was 44.97%, having the revenues showcasing 19.74% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.58B, as it employees total of 88 workers.
Market experts do have their say about Arcturus Therapeutics Holdings Inc. (ARCT)
During the last month, 7 analysts gave the Arcturus Therapeutics Holdings Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 60.56, with a change in the price was noted +4.87. In a similar fashion, Arcturus Therapeutics Holdings Inc. posted a movement of +8.39% for the period of last 100 days, recording 1,355,034 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ARCT is recording 0.06 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.06.
Technical breakdown of Arcturus Therapeutics Holdings Inc. (ARCT)
Raw Stochastic average of Arcturus Therapeutics Holdings Inc. in the period of last 50 days is set at 30.99%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 27.15%. In the last 20 days, the company’s Stochastic %K was 32.54% and its Stochastic %D was recorded 30.93%.
Bearing in mind the latest performance of Arcturus Therapeutics Holdings Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 44.97%. Additionally, trading for the stock in the period of the last six months notably improved by 10.01%, alongside a boost of 418.89% for the period of the last 12 months. The shares increased approximately by 28.90% in the 7-day charts and went up by -40.36% in the period of the last 30 days. Common stock shares were driven by 19.74% during last recorded quarter.